Abstract
Cells shed into the extracellular space a population of membranous vesicles of plasma membrane origin called microparticles (MP). Given the fact that MP are abundantly present in body fluids including plasma, rich in cell-type or disease-specific proteins and formed in conditions of stress and injury, they have been extensively investigated as biomarkers in various diseases. With the advancement in the mass spectrometry-based proteome analysis, the knowledge of the protein composition of plasma MP (PMP) has been intensively expanded, which aids the discovery of novel diagnostic target proteins. However, the lack of standardized and accurate protocols for PMP isolation limits the implementation of PMP as biomarkers in clinical settings. Here, we describe in detail a robust protocol for PMP isolation from human blood plasma via ultracentrifugation followed by label-free quantitative proteome analysis of PMP.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Mause SF, Weber C (2010) Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res 107(9):1047–1057. https://doi.org/10.1161/CIRCRESAHA.110.226456
Inal JM, Kosgodage U, Azam S et al (2013) Blood/plasma secretome and microvesicles. Biochim Biophys Acta 1834(11):2317–2325. https://doi.org/10.1016/j.bbapap.2013.04.005
Morel O, Jesel L, Freyssinet JM et al (2011) Cellular mechanisms underlying the formation of circulating microparticles. Arterioscler Thromb Vasc Biol 31(1):15–26. https://doi.org/10.1161/ATVBAHA.109.200956
Lynch SF, Ludlam CA (2007) Plasma microparticles and vascular disorders. Br J Haematol 137(1):36–48. https://doi.org/10.1111/j.1365-2141.2007.06514.x
Dignat-George F, Boulanger CM (2011) The many faces of endothelial microparticles. Arterioscler Thromb Vasc Biol 31(1):27–33. https://doi.org/10.1161/ATVBAHA.110.218123
Burger D, Schock S, Thompson CS et al (2013) Microparticles: biomarkers and beyond. Clin Sci (Lond) 124(7):423–441. https://doi.org/10.1042/CS20120309
Yuana Y, Bertina RM, Osanto S (2011) Pre-analytical and analytical issues in the analysis of blood microparticles. Thromb Haemost 105(3):396–408. https://doi.org/10.1160/TH10-09-0595
Robert S, Poncelet P, Lacroix R et al (2009) Standardization of platelet-derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: a first step towards multicenter studies? J Thromb Haemost 7(1):190–197. https://doi.org/10.1111/j.1538-7836.2008.03200.x
Ueba T, Haze T, Sugiyama M et al (2008) Level, distribution and correlates of platelet-derived microparticles in healthy individuals with special reference to the metabolic syndrome. Thromb Haemost 100(2):280–285. https://doi.org/10.1160/TH07-11-0668
Smalley DM, Root KE, Cho H et al (2007) Proteomic discovery of 21 proteins expressed in human plasma-derived but not platelet-derived microparticles. Thromb Haemost 97(1):67–80. https://doi.org/10.1160/TH06-02-0066
Aras O, Shet A, Bach RR et al (2004) Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia. Blood 103(12):4545–4553. https://doi.org/10.1182/blood-2003-03-0713
Tesselaar ME, Romijn FP, Van Der Linden IK et al (2007) Microparticle-associated tissue factor activity: a link between cancer and thrombosis? J Thromb Haemost 5(3):520–527. https://doi.org/10.1111/j.1538-7836.2007.02369.x
Yuana Y, Oosterkamp TH, Bahatyrova S et al (2010) Atomic force microscopy: a novel approach to the detection of nanosized blood microparticles. J Thromb Haemost 8(2):315–323. https://doi.org/10.1111/j.1538-7836.2009.03654.x
Miguet L, Pacaud K, Felden C et al (2006) Proteomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimization. Proteomics 6(1):153–171. https://doi.org/10.1002/pmic.200500133
Jin M, Drwal G, Bourgeois T et al (2005) Distinct proteome features of plasma microparticles. Proteomics 5(7):1940–1952. https://doi.org/10.1002/pmic.200401057
Josic D, Clifton JG (2007) Mammalian plasma membrane proteomics. Proteomics 7(16):3010–3029. https://doi.org/10.1002/pmic.200700139
Huang da W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4(1):44–57. https://doi.org/10.1038/nprot.2008.211
Kim DK, Lee J, Kim SR et al (2015) EVpedia: a community web portal for extracellular vesicles research. Bioinformatics 31(6):933–939. https://doi.org/10.1093/bioinformatics/btu741
Tukey JW (1949) Comparing individual means in the analysis of variance. Biometrics 5(2):99–114. https://doi.org/10.2307/3001913
Taleb RSZ, Moez P, Younan D et al (2017) Quantitative proteome analysis of plasma microparticles for the characterization of HCV-induced hepatic cirrhosis and hepatocellular carcinoma. Proteomics Clin Appl 11(11-12). https://doi.org/10.1002/prca.201700014
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Taleb, R.S.Z. et al. (2019). Protein Biomarker Discovery Using Human Blood Plasma Microparticles. In: Brun, V., Couté, Y. (eds) Proteomics for Biomarker Discovery. Methods in Molecular Biology, vol 1959. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-9164-8_4
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9164-8_4
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-9163-1
Online ISBN: 978-1-4939-9164-8
eBook Packages: Springer Protocols